An anonymous reader writes: For the first time data may show that a human being has been successfully rejuvenated by gene therapy, claims Bioviva USA. "In September 2015, then 44 year-old CEO of Bioviva USA Inc. Elizabeth Parrish received two of her own company's experimental gene therapies: one to protect against loss of muscle mass with age, another to battle stem cell depletion responsible for diverse age-related diseases and infirmities." Bypassing America's FDA, the controversial therapies were described by the MIT Technology Review as "do-it-yourself medicine," saying it "raises ethical questions about how quickly such treatments should be tested in people and whether they ought to be developed outside the scrutiny of regulators." "The treatment was originally intended to demonstrate the safety of the latest generation of the therapies," reports Bioviva's web site. "But if early data is accurate, it is already the world's first successful example of telomere lengthening via gene therapy in a human individual."